FDA says compounding pharmacies can keep making weight-loss med tirzepatide, for now
Pharmacists may continue making compounded versions of the weight-loss medication tirzepatide while the U.S. Food and Drug ...
FDA will reconsider decision barring copycat versions of Lilly weight loss drug
The Food and Drug Administration (FDA) said it will reconsider its decision to remove Eli Lilly’s blockbuster weight loss and ...
Scripps News on MSN1 天
FDA is reconsidering its decision to take tirzepatide off its drug shortage list
Pharmacists can continue making compounded versions of generic tirzepatide, the active ingredient in popular medications ...
US FDA to reconsider decision barring compounded versions of Lilly weight loss drug
The U.S. Food and Drug Administration on Friday agreed to reconsider a decision it made last month to bar drug compounders ...
Medscape14 小时
Hospitals Reeling From IV Fluid Shortages in the Aftermath of Hurricane Helene
Hurricane Helene damaged one of the major NC-based manufacturing facilities of IV fluids. What’s being done to help hospitals ...
FDA declares IV fluid shortage in the wake of Helene
The Food and Drug Administration (FDA) on Friday declared shortages of three intravenous drugs produced at a North Carolina ...
pharmaphorum2 天
FDA rethinking block on compounding of Lilly's obesity drug
The US regulator has said that compounders can continue to trade in tirzepatide products while it undertakes a review to ...
NBC DFW8 天
Remember the prescription drug shortages from last year? The problem hasn't gone away
To predict and to mitigate drug shortages, PBMs support voluntary data sharing and policies that allow for the immediate substitution of biosimilar drugs — drugs that are highly similar and have no ...
BioPharma Dive2 天
FDA, facing pressure, to review position on Zepbound, Mounjaro shortage
The agency agreed in court to allow compounding companies to continue producing copycat versions of Lilly’s fast-selling medicines while it reevaluates its recent decision to declare the drugs back in ...
Knockoff weight loss drug sellers are fighting back against Eli Lilly and the FDA
Eli Lilly (LLY) is calling on companies that have been selling off-brand versions of its popular diabetes and weight-loss ...
The Wall Street Journal on MSN13 天
Eli Lilly’s Weight-Loss, Diabetes Drug Shortages Are Over, FDA Says
Eli Lilly has finally made enough supply of its popular medicine tirzepatide to meet soaring demand, which should help the ...
STAT7 天
Compounding group sues FDA for removing Lilly’s obesity drug from its shortages list
A trade group representing compounding pharmacies sued the FDA for a “reckless and arbitrary” decision to remove Eli Lilly's ...